Monitoring drug cravings in patients with opioid use disorder using brain responses
Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials
['FUNDING_SBIR_2'] · NEUROTYPE INC. · NIH-10787065
This study is testing a new device that uses brainwave technology to help people with opioid use disorder understand their cravings when they see things that remind them of opioids, so they can get better support and reduce the chance of relapse.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEUROTYPE INC. (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-10787065 on ClinicalTrials.gov |
What this research studies
This research aims to develop a device that can objectively monitor cravings for opioids triggered by environmental cues in patients with opioid use disorder (OUD). By using electroencephalogram (EEG) technology, the study will measure brain responses to opioid-related cues and compare them to responses elicited by food cues. The goal is to create a tool that can help predict relapse and improve treatment outcomes for individuals struggling with OUD. The research will involve clinical trials to evaluate the effectiveness of this monitoring approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are seeking treatment.
Not a fit: Patients who do not have opioid use disorder or are not seeking treatment for substance use issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new way to predict and manage cravings in patients with opioid use disorder, potentially reducing relapse rates.
How similar studies have performed: Other research has shown promise in using EEG and similar neurophysiological measures to assess cravings and predict relapse in substance use disorders.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- NEUROTYPE INC. — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BURWELL, SCOTT — NEUROTYPE INC.
- Study coordinator: BURWELL, SCOTT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.